Treat atopic dermatitis during pregnancy with safe and effective therapies Amy Zhuang-Yan Disease Management 20 July 2024
Several more myasthenia gravis therapy options now available Caroline FentonConnie Kang Disease Management 20 July 2024
Screen high-risk paediatric patients for non-infectious uveitis and consider its treatment options Simon Fung Disease Management 20 July 2024
Rozanolixizumab in generalized myasthenia gravis: a profile of its use Sheridan M. Hoy Adis Drug Q&A 20 July 2024
The changing landscape of medicare part D coverage: effects of the Inflation Reduction Act (IRA) in dermatology Kennedy SparlingSami JelousiDaniel C. Butler Current Opinion 18 July 2024
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice Chueh Hsuan HsuChueh Lin HsuBogna Grygiel-Górniak Review Article Open access 18 July 2024
Management of orofacial pain starts with careful differentiation of odontogenic and non-odontogenic pain Esther S. KimSimon Fung Disease Management 13 July 2024
Personalise treatment for rosacea by selecting from a range of options for individual features Tina Nie Disease Management 11 July 2024
Long-term topical corticosteroid treatment for atopic dermatitis: an in-depth analysis of safety, efficacy, withdrawal, and patient experiences Alyssa Ingurgio Review Article 09 July 2024
Take an individualized approach when managing women of reproductive age with uterine fibroids Sheridan M. Hoy Practical Issues and Updates 09 July 2024
Medication errors in older patients: a pharmacovigilance perspective Marie-Laure LarocheMichel GuillauminMarie-Blanche Valnet-Rabier Original Research Article 09 July 2024
Corticosteroids are still first-line therapies for bullous pemphigoid, with biologics finding use in difficult-to-treat disease Simon Fung Practical Issues and Updates 05 July 2024
Adis summary of research: Matching‑adjusted indirect comparisons of diroximel fumarate, ponesimod, and teriflunomide for relapsing multiple sclerosis Hannah A. Blair Adis Summary of Research 01 July 2024
Zuranolone in postpartum depression: a profile of its use in the USA Hannah A. Blair Adis Drug Q&A 19 June 2024
Add or switch to systemics and biologics where topical paediatric hidradenitis suppurativa therapy fails Caroline FentonConnie Kang Practical Issues and Updates 18 June 2024
Current and emerging immunobiologic therapies for atopic dermatitis Hemali ShahFrancelia J. EckembrecherKeyvan Nouri Review Article Open access 13 June 2024
Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use Hannah A. Blair Adis Drug Q&A 27 May 2024 Pages: 173 - 180
Dietary supplements may boost memory, but more evidence is required Connie Kang Practical Issues and Updates 15 May 2024 Pages: 185 - 188
Adis summary of research: A 10-year observational study of the use, acceptability and effectiveness of long-acting paliperidone palmitate: implications for clinical decision making Yahiya Y. Syed Adis Summary of Research 01 July 2024 Pages: 192 - 193
Adis summary of research: Safety, tolerability and pharmacokinetics of aripiprazole 2-monthly formulation in patients with schizophrenia or bipolar I disorder Hannah A. Blair Adis Summary of Research 27 June 2024 Pages: 190 - 191
First reports of adverse drug reactions Drug Reactions and Interactions 25 June 2024 Pages: 189 - 189
Aim to alleviate alopecia areata with newly available agents Caroline FentonConnie Kang Practical Issues and Updates 04 June 2024 Pages: 181 - 184
Increasing patient safety due to an implemented ward pharmacist in an interprofessional cancer care team evaluated in a prospective, controlled intervention study Svenja DierkesAnnette FreidankRoland Radziwill Original Research Article 29 April 2024 Pages: 151 - 159
Correction to: Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA Hannah A. Blair Correction Open access 28 April 2024 Pages: 172 - 172
Assessment of rational antibiotic use among children being treated in primary care facilities in Punjab, Pakistan: findings and implications Zia Ul MustafaAmer Hayat KhanBrian Godman Original Research Article 28 April 2024 Pages: 160 - 171
Adjust antimicrobial agent regimens in older patients to correct for changes in pharmacokinetics and to avoid adverse events Simon Fung Drug Reactions and Interactions 28 April 2024 Pages: 145 - 150
Determine and remove the drug trigger, usually antibiotics, that causes acute generalised exanthematous pustulosis Esther S. KimConnie Kang Drug Reactions and Interactions 28 April 2024 Pages: 141 - 144
Adis Summary of Research: Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder Yahiya Y. Syed Adis Summary of Research 06 May 2024 Pages: 139 - 140
Sparsentan in immunoglobulin A nephropathy: a profile of its use Young-A HeoConnie Kang Adis Drug Q&A 29 March 2024 Pages: 101 - 108
What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings? Andrea BushTina BennyMatthew Seamon Current Opinion 28 March 2024 Pages: 131 - 136
Treating paediatric Crohn’s disease is challenging but new treatments hold promise Tina Nie Disease Management 28 March 2024 Pages: 121 - 126
Correction to: Efanesoctocog alfa in hemophilia A: a profile of its use Simon FungHannah A. Blair Correction Open access 21 March 2024 Pages: 138 - 138
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use Tina Nie Correction Open access 21 March 2024 Pages: 137 - 137
Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins Amy Zhuang-Yan Drug Reactions and Interactions 21 March 2024 Pages: 127 - 130
Treat bipolar depression with atypical antipsychotics and mood stabilisers; new therapies require further study Simon Fung Practical Issues and Updates 11 March 2024 Pages: 109 - 114
Get on top of gout with a fresh look at treatment options Caroline FentonConnie Kang Practical Issues and Updates 04 April 2024 Pages: 115 - 120
Evaluation of diclofenac utilization patterns before and after digital risk minimization intervention in outpatient settings in Montenegro Maja StankovicNemanja TurkovicNemanja Rancic Original Research Article 24 February 2024 Pages: 90 - 100
Multisite primary care led amoxicillin challenge pathway to safely remove penicillin allergy label David C. MariKelley M. HensonTaylor A. Banks Therapy in Practice 10 March 2024 Pages: 83 - 89
Administer antidepressants during pregnancy on a case-by-case basis Yvette N. LambSimon Fung Practical Issues and Updates 10 March 2024 Pages: 78 - 82
Metformin reduces the complications of gestational diabetes mellitus but its long-term effects on offspring require further study Simon Fung Practical Issues and Updates 10 March 2024 Pages: 72 - 77
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA Hannah A. Blair Adis Drug Q&A Open access 15 March 2024 Pages: 61 - 71
Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use Simon FungYahiya Y. Syed Adis Drug Q&A 10 March 2024 Pages: 53 - 60
Pirtobrutinib in relapsed or refractory mantle cell lymphoma: a profile of its use Young-A Heo Adis Drug Q&A 27 January 2024 Pages: 45 - 52
Preferably pre-empt pathological scars, or pick from a plethora of therapies Caroline FentonYvette N. Lamb Practical Issues and Updates 08 January 2024 Pages: 22 - 26
Correction to: Tezepelumab in severe asthma: a profile of its use Yahiya Y. Syed Correction Open access 05 January 2024 Pages: 43 - 43
Platelet-rich plasma therapy for chronic cutaneous wounds stratified by etiology: a systematic review of randomized clinical trials Verónica Salgado-PachecoMontserrat Serra-MasMarta Otero-Viñas Systematic Review Open access 28 February 2024 Pages: 31 - 42
Expand the treatment horizon of premenstrual dysphoric disorder with targeted therapeutic approaches Young-A Heo Practical Issues and Updates 24 February 2024 Pages: 27 - 30
Treat borderline personality disorder with psychotherapy and concomitant psychiatric disorders with adjuvant pharmacotherapy Esther S. KimYvette N. Lamb Disease Management 24 February 2024 Pages: 17 - 21
Efanesoctocog alfa in hemophilia A: a profile of its use Simon FungHannah A. Blair Adis Drug Q&A Open access 24 February 2024 Pages: 9 - 16
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use Tina Nie Adis Drug Q&A Open access 24 February 2024 Pages: 1 - 8
